HEPION PHARMACEUTICALS, INC. (HEPA) Return on equity 2020–2023
HEPION PHARMACEUTICALS, INC. (HEPA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-672.0%FY2023 · since FY2020: -50.2% → -672.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -672.0% | -587.3 pp |
| FY2022 | -84.6% | -49.5 pp |
| FY2021 | -35.2% | +15.0 pp |
| FY2020 | -50.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice